These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2207373)
1. Isolation and characterization of beta-hydroxypropionic acid- and hydroxyacetic acid-uroporphyrin I in the urine of a patient with congenital erythropoietic porphyria by high performance liquid chromatography and liquid secondary ion mass spectrometry. Guo R; Chai W; Rideout JM; Lawson AM; Lim CK Biomed Chromatogr; 1990 Jul; 4(4):141-3. PubMed ID: 2207373 [TBL] [Abstract][Full Text] [Related]
2. Identification of peroxyacetic acid uroporphyrin I in the urine of patients with congenital erythropoietic porphyria by liquid chromatography and mass spectrometry. Guo R; Rideout JM; Chai W; Lawson AM; Lim CK Biomed Chromatogr; 1991 Mar; 5(2):53-6. PubMed ID: 1868257 [TBL] [Abstract][Full Text] [Related]
3. Identification of meso-hydroxyuroporphyrin I in the urine of a patient with congenital erythropoietic porphyria. Guo R; Rideout JM; Lim CK Biochem J; 1989 Nov; 264(1):293-5. PubMed ID: 2604713 [TBL] [Abstract][Full Text] [Related]
4. Preparation and separation of hydroxy derivatives of uroporphyrinogen I by high-performance liquid chromatography with electrochemical detection. Gu G; Lim CK J Chromatogr A; 1996 Jan; 722(1-2):245-8. PubMed ID: 9019298 [TBL] [Abstract][Full Text] [Related]
5. Determination of hydroxy and peroxy acid derivatives of uroporphyrin in the plasma of patients with congenital erythropoietic porphyria by high-performance liquid chromatography. Guo R; Lim CK J Chromatogr; 1991 Jul; 550(1-2):603-7. PubMed ID: 1774232 [TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of position isomers of penta-and hexa-carboxylated porphyrins belonging to the isomer III series in a case of congenital erythropoietic porphyria. Eriksen L; Eriksen N Scand J Clin Lab Invest; 1977 Jun; 37(4):357-61. PubMed ID: 616062 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry. Luo J; Lim CK Biomed Chromatogr; 1995; 9(3):113-22. PubMed ID: 7655298 [TBL] [Abstract][Full Text] [Related]
8. Isocratic ion-pair high-performance liquid chromatographic methods for the determination of uroporphyrin and coproporphyrin type II and IV isomers in human urine. Jacob K; Egeler E; Neumeier D; Knedel M J Chromatogr; 1989 May; 468():329-38. PubMed ID: 2732289 [TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography/electrospray ionization tandem mass spectrometry of hydroxylated uroporphyrin and urochlorin derivatives formed by photochemical oxidation of uroporphyrinogen I. Danton M; Lim CK Biomed Chromatogr; 2007 May; 21(5):534-45. PubMed ID: 17345569 [TBL] [Abstract][Full Text] [Related]
10. Porphyria: genetic and acquired. Cripps DJ IARC Sci Publ; 1986; (77):549-66. PubMed ID: 3298037 [TBL] [Abstract][Full Text] [Related]
11. Pyridoxal 5-phosphate therapy in a patient with myelodysplastic syndrome and adult onset congenital erythropoietic porphyria. Yamauchi K; Kushibiki Y Br J Haematol; 1992 Aug; 81(4):614-5. PubMed ID: 1390252 [No Abstract] [Full Text] [Related]
13. Application of ion pair high performance liquid chromatography to the analysis of porphyrins in clinical samples. Jacob K; Luppa P Biomed Chromatogr; 1991 May; 5(3):122-7. PubMed ID: 1863806 [TBL] [Abstract][Full Text] [Related]
14. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria. Eriksen L; Eriksen N Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698 [No Abstract] [Full Text] [Related]
15. Family study in congenital erythropoietic porphyria. Darocha T; Weremowicz J; Gregor A S Afr Med J; 1971 Sep; ():231-7. PubMed ID: 5150286 [No Abstract] [Full Text] [Related]
16. Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria. Romeo G; Levin EY Proc Natl Acad Sci U S A; 1969 Jul; 63(3):856-63. PubMed ID: 5259767 [TBL] [Abstract][Full Text] [Related]
17. Establishment of modern examining procedures for diagnosis of porphyrias. Csiba A; Szécsényi-Nagy L Acta Physiol Hung; 1985; 66(1):39-46. PubMed ID: 4036642 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of D-glucaric of D-glucaric acid determination in the urine of porphyria cutanea tarda patients]. Adjarov D; Kerimova M; Ivanov E; Naidenova E Dermatol Monatsschr; 1985; 171(4):233-5. PubMed ID: 2861119 [No Abstract] [Full Text] [Related]
19. [Gunther's congenital erythropoietic porphyria and carotenoids. Therapeutic attempt of 4 years]. Maleville J; Babin JP; Mollard S; Martin C; Nordmann Y; Guillet G Ann Dermatol Venereol; 1982; 109(10):883-7. PubMed ID: 7171196 [No Abstract] [Full Text] [Related]
20. Quantitative determination of free uroporphyrin, uroporphyrin zinc complex salt and porphobilinogen in urine porphyria. BRUGSCH J Z Gesamte Inn Med; 1952 Dec; 7(23):1086-90. PubMed ID: 13049933 [No Abstract] [Full Text] [Related] [Next] [New Search]